Page last updated: 2024-10-17

3-hydroxybutyric acid and Inflammatory Bowel Diseases

3-hydroxybutyric acid has been researched along with Inflammatory Bowel Diseases in 2 studies

3-Hydroxybutyric Acid: BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
3-hydroxybutyric acid : A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.

Inflammatory Bowel Diseases: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Huang, C1
Wang, J1
Liu, H1
Huang, R1
Yan, X1
Song, M1
Tan, G1
Zhi, F1
Suzuki, R1
Mishima, M1
Nagane, M1
Mizugaki, H1
Suzuki, T1
Komuro, M1
Shimizu, T1
Fukuyama, T1
Takeda, S1
Ogata, M1
Miyamoto, T1
Aihara, N1
Kamiie, J1
Kamisuki, S1
Yokaryo, H1
Yamashita, T1
Satoh, T1

Other Studies

2 other studies available for 3-hydroxybutyric acid and Inflammatory Bowel Diseases

ArticleYear
Ketone body β-hydroxybutyrate ameliorates colitis by promoting M2 macrophage polarization through the STAT6-dependent signaling pathway.
    BMC medicine, 2022, 04-15, Volume: 20, Issue:1

    Topics: 3-Hydroxybutyric Acid; Animals; Colitis; Dextran Sulfate; Disease Models, Animal; Humans; Inflammati

2022
The novel sustained 3-hydroxybutyrate donor poly-D-3-hydroxybutyric acid prevents inflammatory bowel disease through upregulation of regulatory T-cells.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2023, Volume: 37, Issue:1

    Topics: 3-Hydroxybutyric Acid; Humans; Hydroxybutyrates; Inflammatory Bowel Diseases; Polyesters; T-Lymphocy

2023